CardiologyOnline
News
Drugs
Xagena Medicine
Xagena.net
Patients with acute coronary syndrome at risk of adverse events within 3 months after stopping Clopidogrel treatment
Coronary artery bypass graft surgery: MC-1 does not appear to reduce risk of myocardial infarction or death
Crestor can reduce plaques that cause myocardial infarction
Statins may also modestly reduce blood pressure
Elderly patients: intensified heart failure therapy does not improve survival free of all-cause hospitalisations
Igroton reduces risk for a type of heart failure that is more common among women
Peripheral arterial obstructive disease: oral Buflomedil in the prevention of cardiovascular events
Narrowed coronary arteries: Endeavor, a Zotarolimus-eluting stent
Young myocardial infarction survivors: smoking is greatest predictor of recurrent cardiac events
Metoprolol increases the risk of death and stroke around the time of non-cardiac surgery
Vytorin does not slow progression of aortic valve disease Aortic in patients with stenosis
Garlic does not reduce cholesterol levels
Women: reduced risk of dying linked to long-term use of Aspirin
Percutaneous coronary intervention reduces the long-term risk of MACE among heart attack survivors with silent ischemia
Acute coronary syndrome: recommended treatments linked with reductions in rates of heart failure, stroke, heart attack and death
Levosimendan does not improve survival for patients with decompensated heart failure
Coronary artery disease: Celecoxib after stent implantation can reduce the need for revascularisation of the target lesion
Acute myocardial infarction: drug eluting stents should be used with caution
Peripheral arterial disease linked to excessive cardiovascular mortality
PCI for stent thrombosis is associated with high rate of adverse clinical outcome
Atrioventricular junction ablation in addition to cardiac resynchronisation therapy in heart failure patients with atrial fibrillation
Candesartan reduces the incidence of major adverse cardiovascular events in patients with impaired renal function
Treating depression may reduce cardiac risk in patients with acute coronary syndrome
Lack of evidence of a Clopidogrel-statin interaction
Primary prevention of atherothrombotic events: an excess of mortality with dual-antiplatelet therapy
Sirolimus improves kidney function and prevent coronary artery disease in heart transplant
Revised guidelines for unstable angina and non-ST-elevation myocardial infarction
Waist-to-hip ratio may better predict cardiovascular risk than body mass index
Torcetrapib fails to slow progression of coronary disease
Rosuvastatin effective at halting early atherosclerosis
Next Pages [
1
]
2
3
4
5
6
7
8
9
10
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
